Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
October 16, 2024Inpharmatis Team Participated in RAPS Euro Convergence 2024
Inpharmatis Team participated in the RAPS Euro Convergence 2024, held 6-8 May in Berlin. This conference served as a platform for insightful exchanges, presenting the latest trends, and innovations shaping the regulatory landscape in healthcare.
We extend our gratitude to all who visited our booth during this event! At Inpharmatis, we have expanded our network of clients, developed valuable connections, and engaged in conversations that drive our company forward.
If you have any further inquiries or wish to explore opportunities for collaboration, reach out to us at info@inpharmatis.com.
Stay tuned for more updates and insights from Inpharmatis as we continue to lead the way in regulatory expertise within the Life Science industry.
Dr. Polina Dombure to Speak at TOPRA Webinar "Navigating Regulatory Changes in Moldova and Ukraine"
October 16, 2024Полина Домбуре, генеральный директор Inpharmatis Group, примет участие в CPHI Milan 8-10 октября 2024
September 25, 2024Dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI Milan in 8-10 October 2024
September 25, 2024Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
September 13, 2024Dr. Polina Dombure to Speak at TOPRA Webinar on “Overcoming Regulatory Challenges in Azerbaijan and Georgia”
September 13, 2024Особенности процедуры пользовательского тестирования листка-вкладыша в Казахстане
May 28, 2024Peculiarities of PIL Readability User Testing Procedure in Kazakhstan
May 28, 2024Требования к клиническим испытаниям при регистрации медицинских изделий в России
May 21, 2024Clinical Trials Requirements for Medical Device Registration in Russia
May 21, 2024